Cargando…
Angiostatin generating capacity and anti-tumour effects of D-penicillamine and plasminogen activators
BACKGROUND: Upregulation of endogenous angiostatin levels may constitute a novel anti-angiogenic, and therefore anti-tumor therapy. In vitro, angiostatin generation is a two-step process, starting with the conversion of plasminogen to plasmin by plasminogen activators (PAs). Next, plasmin excises an...
Autores principales: | de Groot-Besseling, Renate RJ, Ruers, Theo JM, Lamers-Elemans, Iris L, Maass, Cathy N, de Waal, Robert MW, Westphal, Johan R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1560151/ https://www.ncbi.nlm.nih.gov/pubmed/16753063 http://dx.doi.org/10.1186/1471-2407-6-149 |
Ejemplares similares
-
Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen
por: Heidtmann, H-H, et al.
Publicado: (1999) -
Linoleic acid enhances angiogenesis through suppression of angiostatin induced by plasminogen activator inhibitor 1
por: Nishioka, N, et al.
Publicado: (2011) -
Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen
por: Brauer, Rena, et al.
Publicado: (2011) -
Penicillamine Neurotoxicity: An Hypothesis
por: Walshe, J. M.
Publicado: (2011) -
Historical Perspectives of Penicillamine
por: Fernandes, Luke, et al.
Publicado: (1980)